Current research info

Impentri is currently being advanced through human trials, with the first such trial having started in Nov in 2017, and the second in March 2020.

Details of current phase of clinical development

The second trial investigates Covid-19 patients, and the transition from 'severe' to 'critical' stages of the condition, in which they are artifically ventilated in an ICU. We hope we can delay or prevent this transition, as a result of which many patients coud be saved, with concomitant relief on scarce resources such as ventilators. Full details available on the EU Clinical trials register.

The first trial, which established product safety, involved a challenge test to human volunteers, with full details available on the website.

Phase 1
Phase 2
Phase 3
Commercial Release